Click below to see the vote description.
|
Roll Call 108.
(S. 3187) On an amendment to allow American consumers to import cheaper prescription drugs from Canada
May 24, 2012.
|
N |
Y |
L |
|
Roll Call 105.
(S. 3187) On an amendment to bar prescription drug companies from paying other companies not to produce competing medications
May 24, 2012.
|
Y |
Y |
L |
|
Roll Call 172.
(H.R. 2112) On an amendment that would have allowed for the importation of pharmaceutical drugs from Canada
Oct 20, 2011.
|
N |
Y |
L |
|
Roll Call 114.
(H.R. 2055) On a motion to table (kill) an amendment that would have required veterans receiving disability payments for illnesses associated with Agent Orange to prove that Agent Orange was the cause of their medical condition
Jul 20, 2011.
|
Y |
Y |
W |
|
Roll Call 59.
(H. Con. Res. 35) Final passage of legislation effectively defunding the landmark 2010 health care reform law that expanded health insurance coverage to 31 million previously uninsured Americans, and prohibited insurance companies from denying coverage to individuals with pre-existing medical conditions
Apr 14, 2011.
|
N |
N |
W |
|
Roll Call 353.
HR 3590. (Health care overhaul) Motion to begin debate on a bill that would overhaul the health care system/On the motion
Nov 21, 2009.
|
Y |
Y |
W |
|
All votes listed below this point were cast while this member served in the House of
Representatives prior to becoming a senator. These House votes are not included in our
calculation of either the member's Crucial Lifetime Progressive score or Overall Lifetime
Progressive score in this category; those scores are based only on the votes the member
has taken while serving in the Senate.
|
|
Roll Call 23.
Requiring the federal government to negotiate with drug companies for the prices of drugs covered under Medicare (H.R. 4)/On passage
Jan 12, 2007.
|
Y |
Y |
W |
|
Roll Call 22.
Requiring the federal government to negotiate with drug companies for the prices of drugs covered under Medicare (H.R. 4)/Motion to recommit with instructions to add language that ensures that beneficiaries will not be restricted in their access to prescription drugs and that the negotiations will not result in the price increase of prescription drugs for any group
Jan 12, 2007.
|
N |
N |
W |
|
Roll Call 20.
Federal funding of embryonic stem cell research (H.R. 3)/On passage
Jan 11, 2007.
|
Y |
Y |
W |
|
Roll Call 19.
Federal funding of embryonic stem cell research (H.R. 3)/Motion to recommit the bill to the Energy and Commerce Committee with instructions to include language prohibiting entities involved in a certain type of cell transfer associated with human cloning from receiving federal funding
Jan 11, 2007.
|
N |
N |
W |
![[POW!]](images/boxer_l2.gif)